NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients

Iimura, Y; Shimomura, H; Yasu, T; Imanaka, K; Ogawa, R; Ito, A; Suzuki, K; Yamaguchi, G; Kawasaki, N; Konaka, C

Iimura, Y (reprint author), Int Univ Hlth & Welf Ichikawa Hosp, Dept Pharm, 6-1-14 Kounodai, Ichikawa, Chiba 2720827, Japan.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018; 56 (11): 551

Abstract

Objectives: Skin rash is a common adverse event induced by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). Here, we aimed to p......

Full Text Link